In general, TGF-β conveys signals through phosphorylation of Smad2/3, but it also can transduce signals via Ras/ERK1/2, PI3 K, p38, and RhoA pathways, the latter processes augmenting its tumor promoting activity [16–19]. The gene discussed is SMAD2; the disease is neoplasm.